←
Trends in Cancer5,026 posts
Trends in Cancer avatar

Trends in Cancer

@trendscancer

Trends in Cancer is a leading reviews journal covering advances in cancer research and oncology published by Cell Press. Tweets by Editor Danielle Loughlin.

◷ Joined September 2015▧ 674 Photos and videos
Eric Topol avatar
⟳ Trends in Cancer retweeted
Eric Topol@EricTopol·Oct 12

Engineering T cells for immunotherapy vs cancer had already had marked success in certain types. But there's a next generation in the hopper, as reviewed today @Cancer_Cell, that ought to help take the field much further into solid tumors cell.com/cancer-cell/fulltex…

Post attachment
Yakup Ergün avatar
⟳ Trends in Cancer retweeted
Yakup Ergün@dr_yakupergun·Sep 7

CDK4/6 inhibitors arrest the cell cycle by activating Rb. But the authors provide compelling evidence that the story does not end there. A new Nature study shows that hypophosphorylated Rb unexpectedly enhances ER-mediated transcription. Rb relocates to enhancer regions and reactivates proliferative ER-target genes, including CCND1. So, paradoxically, CDK4/6 inhibition leads to: E2F ↓ → proliferation ↓ but at the same time Rb → ER transcription ↑ → proliferative counter-response ↑ Endocrine therapy shuts down this second pathway. This finding reveals a new mechanism that may help explain the strong biological rationale for combining CDK4/6 inhibition with endocrine therapy, while also pointing to a potential mechanism of resistance. nature.com/articles/s41586-0…

Post attachment
Dvir Aran avatar
⟳ Trends in Cancer retweeted
Dvir Aran@dvir_a·Sep 1

Our paper is out in @Cancer_Cell! We started this project almost 5 years ago with the idea that to understand why some cancer patients respond to immunotherapy and others do not, we may need to look beyond the tumor before treatment. Immunotherapy is not just a test of a pre-existing state; it is a perturbation. It changes the tumor immune microenvironment. So the question became: can the direction of that change explain response? authors.elsevier.com/a/1niWC…

Post attachment